Company intelligence / Profile preview
HealthBio
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
HealthBio has developed a proprietary diagnostic and therapeutic platform targeting the root cause of chronic inflammation in conditions like Long COVID. Their patented combination therapy with maraviroc and atorvastatin addresses persistent immune activation via the CCR5 pathway. Pre-trial data reportedly show strong statistical significance in symptom improvement. The company received FDA approval to begin a double-blind placebo-controlled Phase 2 trial in January 2024; patient enrollment began March 2025. Over 12,000 patients have been treated under protocol since inception with promising results reported anecdotally/preliminarily.
- Therapeutic areas
- ImmunologyInfectious Diseases
- Modalities
- Small molecules (e.g., maraviroc, atorvastatin)Precision diagnostics using machine learning and AI
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Investment partnership with Boomerang Catapult VC firm.
Beyond the preview
Go deeper on HealthBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HealthBio.